Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose in Virginia
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Virginia
| Provider | Medicare | Services |
|---|---|---|
| Minneci, Peter MD | $58.72 | 1.5K |
| Ebrom, Pierson D.O. | $58.60 | 1.4K |
| Hollander, Caryn MD | $58.44 | 1.1K |
| Carlson, Jeffrey MD | $58.10 | 485 |
| Haynes, Boyd MD | $58.06 | 391 |
| Burrow, John David D.O. | $57.61 | 279 |
| Keenan, Patricia PA-C | $54.46 | 278 |
| Mcfarland, Mark DO | $57.98 | 257 |
| Hagerty, Mary MD | $57.25 | 237 |
Virginia Pricing in Context
In Virginia, CPT code J7321 (Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose) carries an average Medicare payment of $57.54 — 0% below the national benchmark of $57.56. 176 providers across the state submitted claims for this procedure in 2023, performing 12.1K total services. Individual payments in VA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Virginia is $241.11, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Virginia sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Virginia lands near $161.87, with self-pay cash prices typically around $121.49. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose cost in Virginia?
The average Medicare payment for Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose in Virginia is $57.54, which is 0% below the national average of $57.56. Providers in VA typically bill $241.11 for this procedure.
What does Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose cost with insurance in Virginia?
With commercial insurance in Virginia, Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose costs an estimated $161.87. Without insurance, the estimated cash price is $121.49. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose in Virginia?
176 providers in Virginia billed Medicare for Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose in 2023, performing 12.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose cheaper in Virginia than the national average?
Yes — Hyaluronan Or Derivative, Hyalgan, Supartz Or Visco-3, For Intra-Articular Injection, Per Dose costs 0% below the national average in Virginia. The state average Medicare payment is $57.54 compared to $57.56 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.